1,667
Total Claims
$1.3M
Drug Cost
461
Beneficiaries
$2,803
Cost/Patient
Peer Comparison vs. 13,195 Dermatology providers
+132%
Cost per patient vs peers
$2,803 vs $1,209 avg
+69%
Brand preference vs peers
12.7% vs 7.5% avg
Brand vs Generic
87% generic
Brand: 205 claims · $1.2M
Generic: 1,411 claims · $64K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Upadacitinib | 42 | $269K |
| Dupilumab | 47 | $188K |
| Secukinumab | 14 | $160K |
| Dupilumab | 38 | $146K |
| Adalimumab | 13 | $96K |
| Clobetasol Propionate | 134 | $11K |
| Fluorouracil | 58 | $6,466 |
| Metronidazole | 46 | $4,945 |
| Betamethasone Dipropionate | 68 | $4,633 |
| Ketoconazole | 141 | $4,482 |
| Doxycycline Monohydrate | 131 | $3,586 |
| Doxycycline Hyclate | 55 | $2,418 |
| Clindamycin Phosphate | 33 | $2,311 |
| Imiquimod | 40 | $2,042 |
| Triamcinolone Acetonide | 95 | $2,021 |
Prescribing Profile
31
Unique Drugs
Patient Profile
75
Avg Age
50%
Female
1.11
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About